LOGIN  |  REGISTER
Chimerix
Amneal Pharmaceuticals

DocGo Announces Upcoming Participation in Three Investor Conferences in September

September 05, 2023 | Last Trade: US$1.50 0.00 0.00

NEW YORK / Sep 05, 2023 / Business Wire / DocGo Inc (Nasdaq: DCGO), a leading provider of last-mile mobile health services, announced today that Anthony Capone, Chief Executive Officer will present at three different investor conferences in September 2023.

On Wednesday, September 13, 2023, at 3:35 Eastern Time, Mr. Capone will participate in a fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference in New York City. A webcast of the event will be available on the investor relations section of DocGo’s website at https://ir.docgo.com/.

On Tuesday, September 19, Mr. Capone will be meeting with investors virtually during the Northland Investor Conference.

On Wednesday, September 27 at 1:15 PM Eastern Time, Mr. Capone will participate in a fireside chat at the 2023 Cantor Global Healthcare Conference in New York City. A webcast of the event will be available on the investor relations section of DocGo’s website at https://ir.docgo.com/.

About DocGo

DocGo is leading the proactive healthcare revolution with an innovative care delivery platform that includes mobile health services, remote patient monitoring and ambulance services. DocGo disrupts the traditional four-wall healthcare system by providing high quality, highly affordable care to patients where and when they need it. DocGo's proprietary, AI-powered technology and dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks, and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient's home or workplace. Together with DocGo's integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care.For more information, please visit www.docgo.com.

Assertio

Stock Quote

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page